Accessing Enhertu in India & Other Countries

 Enhertu (Fam-trastuzumab deruxtecan-nxki) has been developed by joining a couple of different types of anti-cancer medicines together to develop one medicine named antibody-drug conjugate (ADC). Enhertu is chemotherapy and is also a targeted therapy anti-cancer medicine. The medicine is commercially available as an injection: 100 mg lyophilized powder in a single-dose vial. Enhertu injection cost in India is calculated on behalf of the specific patient's needs.

Enhertu is an FDA-approved medicinal product that is widely prescribed for multiple cancer treatments. Multiple indications of Enhertu are as follows:

HER2-positive Breast Cancer: Enhertu is used for the treatment of breast cancer in adults that cannot be eliminated by surgery or that has progressed to other parts of the body (metastatic) and

  • patients have already been treated with an anti-HER2 breast cancer therapy:
  • for their metastatic disease, or
  • have breast cancer that has returned during or within six months of completing therapy for their early-stage breast cancer.

HER2-low (IHC 1+ or IHC 2+/ISH-) Breast Cancer: Enhertu 100 mg injection is used to treat breast cancer in adults that cannot be eliminated by surgery or that has progressed to other organs of the body (metastatic) and

  • who have previously been treated with chemotherapy in the metastatic setting or
  • Cancer has returned during or within 6-months of finishing adjuvant chemotherapy.

HER2-positive Stomach Cancer: Enhertu injection is used for the treatment of gastroesophageal junction (GEJ) adenocarcinoma cancer in adults and

  • they have previously been treated with a trastuzumab-based regimen and have
  • progressed to areas surrounding to stomach (locally advanced) or
  • that has progressed to other organs of the body (metastatic).

HER2 (ERBB2) mutations activating Non-small cell lung cancer (NSCLC): Enhertu 100 mg is used to treat adults that have non-small cell lung cancer that cannot be eliminated by surgery or that has progressed to other parts of the body (metastatic), and 

  • the patient has previously been treated with systemic therapy
  • activating HER2 (ERBB2) mutations have been noticed by an FDA-approved test.

The recommended dosage of Enhertu for all indications is given as an IV (intravenous) infusion every 3 weeks.

Reliable Procurement of Enhertu (trastuzumab deruxtecan):

The price of Enhertu in India and other countries (where it has not been approved or is not available) is mostly affected due to the lack of readily available access to this medicine. Hard-to-find specialty drugs like Enhertu injections need temperature-specific storage as well as shipment/transportation provisions. The quality of Enhertu directly depends on the storage and shipment standards. This typically matters for both Indian and International patients who are looking for hard-to-access advanced and specific drugs that are not available right now in the country. 

In order to the initiate import process to buy Enhertu injections online from any international territory, patients need to get an import license from CDSCO. If you are searching for a service provider that can help source Enhertu through legal channels, then THE INDIAN PHARMA (TIP), a GDP-certified consultant company can help you legally. We are experienced in supplying advanced and hard-to-find medicines like sourcing Enhertu in India and other places.

Contact THE INDIAN PHARMA (TIP) via TOLL-FREE: 1800-889-1064 or Call/WhatsApp: +91 9310090915. We can be counted on for reliable procurement.

Reference:

https://www.enhertu.com/

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found ...
Read more

Lenvatinib Medication Guide

Lenvatinib is recommended for treating patients with locally recurrent, progressive, metastatic, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC), together with everolimus for advanced renal cell carcinoma and for hepatocellular carcinoma.  Here are a few important points for patients before taking Lenvatinib:- Female patients who are able to become pregnant must use an effective method of birth control while on the treatment with lenvatinib and for at least 2 weeks after its last dose. Discuss with your doctor about the birth control methods you can use during this time. Lenvatinib is taken at the same time each and every day. If a patient misses any dose, and it cannot be consumed within 12 hours, then that dose must be skipped and the next dose should be consumed at the usual time of administration. The recommended dose is lenvatinib 24 mg (two lenvatinib 10 mg capsules and one lenvatinib 4 mg capsule) orally, taken once in a day, either with or...
Read more

Difference Between Multiple Myeloma And Leukemia

Image
What is multiple myeloma:  This is also known as plasma cell myeloma or Kahler's disease. It is a cancer in plasma cells that typically produce antibodies. When there is only one tumor present it is called as plasmacytoma and when more than one then called as multiple myeloma. The main cause of myeloma is unknown but the major risk factors are obesity,  inheritance chemicals, radiation, etc. With the effect of cancer, there is an abnormality in plasma cells that produces abnormal antibodies that can cause kidney problems. At the initial stage, there is no sign and symptoms but with the advancement of time bone pain, bleeding, anemia and frequent infections are the common symptoms. Multiple myeloma is diagnosed with the help of blood or urine tests or bone marrow biopsy. And the medication of multiple myeloma includes: Chemotherapy- There are several drugs that are used in the treatment of multiple myeloma such as doxorubicin, etoposide, cisplatin, cyclophosphami...
Read more